Fluconazole prophylaxis in preterm infants: a systematic review

ABSTRACT Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis. Methods: This is a systematic review with search at databases: PubMed, Capes Portal, Virtual Health Library (BVS - Biblioteca Virtual em Saúde)/Lilacs, Scopus and Cochrane. The keywords used were: "Antifungal", "Candida" "Fluconazole prophylaxis" and "Preterm infants". Results: Invasive Candidiasis was evaluated in all the twelve items. In eleven of them, there was a statistically significant difference between the groups receiving prophylactic fluconazole, with lower frequency of Invasive Candidiasis, compared to placebo or no prophylaxis group. Colonization by Candida species was also evaluated in five studies; four of them presented statistically lower proportion of colonization in patients with Fluconazole prophylaxis, compared to placebo or no drugs. In one study, there was a significant difference, favoring the use of fluconazole, and reduction of death. Conclusion: Studies indicate the effectiveness of prophylaxis with fluconazole, with reduction in the incidence of colonization and invasive fungal disease. The benefits of prophylaxis should be evaluated considering the incidence of candidiasis in the unit, the mortality associated with candidiasis, the safety and toxicity of short and long-term medication, and the potential for development of resistant pathogens.

Saved in:
Bibliographic Details
Main Authors: Rios,Juliana Ferreira da Silva, Camargos,Paulo Augusto Moreira, Corrêa,Luísa Petri, Romanelli,Roberta Maia de Castro
Format: Digital revista
Language:English
Published: Brazilian Society of Infectious Diseases 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000300333
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1413-86702017000300333
record_format ojs
spelling oai:scielo:S1413-867020170003003332017-06-19Fluconazole prophylaxis in preterm infants: a systematic reviewRios,Juliana Ferreira da SilvaCamargos,Paulo Augusto MoreiraCorrêa,Luísa PetriRomanelli,Roberta Maia de Castro Antifungal Candida Fluconazole prophylaxis Preterm infants ABSTRACT Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis. Methods: This is a systematic review with search at databases: PubMed, Capes Portal, Virtual Health Library (BVS - Biblioteca Virtual em Saúde)/Lilacs, Scopus and Cochrane. The keywords used were: "Antifungal", "Candida" "Fluconazole prophylaxis" and "Preterm infants". Results: Invasive Candidiasis was evaluated in all the twelve items. In eleven of them, there was a statistically significant difference between the groups receiving prophylactic fluconazole, with lower frequency of Invasive Candidiasis, compared to placebo or no prophylaxis group. Colonization by Candida species was also evaluated in five studies; four of them presented statistically lower proportion of colonization in patients with Fluconazole prophylaxis, compared to placebo or no drugs. In one study, there was a significant difference, favoring the use of fluconazole, and reduction of death. Conclusion: Studies indicate the effectiveness of prophylaxis with fluconazole, with reduction in the incidence of colonization and invasive fungal disease. The benefits of prophylaxis should be evaluated considering the incidence of candidiasis in the unit, the mortality associated with candidiasis, the safety and toxicity of short and long-term medication, and the potential for development of resistant pathogens.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.21 n.3 20172017-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000300333en10.1016/j.bjid.2017.01.008
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Rios,Juliana Ferreira da Silva
Camargos,Paulo Augusto Moreira
Corrêa,Luísa Petri
Romanelli,Roberta Maia de Castro
spellingShingle Rios,Juliana Ferreira da Silva
Camargos,Paulo Augusto Moreira
Corrêa,Luísa Petri
Romanelli,Roberta Maia de Castro
Fluconazole prophylaxis in preterm infants: a systematic review
author_facet Rios,Juliana Ferreira da Silva
Camargos,Paulo Augusto Moreira
Corrêa,Luísa Petri
Romanelli,Roberta Maia de Castro
author_sort Rios,Juliana Ferreira da Silva
title Fluconazole prophylaxis in preterm infants: a systematic review
title_short Fluconazole prophylaxis in preterm infants: a systematic review
title_full Fluconazole prophylaxis in preterm infants: a systematic review
title_fullStr Fluconazole prophylaxis in preterm infants: a systematic review
title_full_unstemmed Fluconazole prophylaxis in preterm infants: a systematic review
title_sort fluconazole prophylaxis in preterm infants: a systematic review
description ABSTRACT Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis. Methods: This is a systematic review with search at databases: PubMed, Capes Portal, Virtual Health Library (BVS - Biblioteca Virtual em Saúde)/Lilacs, Scopus and Cochrane. The keywords used were: "Antifungal", "Candida" "Fluconazole prophylaxis" and "Preterm infants". Results: Invasive Candidiasis was evaluated in all the twelve items. In eleven of them, there was a statistically significant difference between the groups receiving prophylactic fluconazole, with lower frequency of Invasive Candidiasis, compared to placebo or no prophylaxis group. Colonization by Candida species was also evaluated in five studies; four of them presented statistically lower proportion of colonization in patients with Fluconazole prophylaxis, compared to placebo or no drugs. In one study, there was a significant difference, favoring the use of fluconazole, and reduction of death. Conclusion: Studies indicate the effectiveness of prophylaxis with fluconazole, with reduction in the incidence of colonization and invasive fungal disease. The benefits of prophylaxis should be evaluated considering the incidence of candidiasis in the unit, the mortality associated with candidiasis, the safety and toxicity of short and long-term medication, and the potential for development of resistant pathogens.
publisher Brazilian Society of Infectious Diseases
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000300333
work_keys_str_mv AT riosjulianaferreiradasilva fluconazoleprophylaxisinpreterminfantsasystematicreview
AT camargospauloaugustomoreira fluconazoleprophylaxisinpreterminfantsasystematicreview
AT correaluisapetri fluconazoleprophylaxisinpreterminfantsasystematicreview
AT romanellirobertamaiadecastro fluconazoleprophylaxisinpreterminfantsasystematicreview
_version_ 1756416542215503872